-

Biosynth Carbosynth, vivitide and Pepscan Rebrand to Biosynth

Rebranding aligns core Biosynth Group members across Complex Chemical and Peptide Manufacturing Services and Catalog Business.

STAAD, Switzerland--(BUSINESS WIRE)--Biosynth Carbosynth, vivitide and Pepscan are pleased to announce today their rebranding to Biosynth to match their parent group and the launch of their site at www.biosynth.com.

Biosynth is a global supplier of critical products and services to the life sciences industry, across the areas of complex chemicals, quality peptides and key biological reagents. In combination with their research product portfolio of more than 600K catalog products across all three areas, Biosynth partners with customers from their first idea to finished product, across research, development and commercial supply of key materials.

The new branding evokes the unique combinations that Biosynth offers, where Products meet Services and where Chemistry meets Biology, Biosynth is at “The Edge of Innovation.”

Dr. Urs Spitz, CEO and President of Biosynth, said, “We are thrilled to be unveiling our new Biosynth brand today, and to be formally integrating Pepscan and vivitide into the organization. We have long been the go to provider of complex chemicals across carbohydrates, nucleoside, enzyme substrates and beyond, and now have such breadth across peptides. We knew it was the right time to bring us all together so our customers can go to one place for all their needs.”

Editor’s notes

About Biosynth

Biosynth is a supplier of critical materials, securing life sciences supply chains with global research, manufacturing and distribution facilities. Supplying the pharmaceutical, life science and diagnostic sectors; where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. With an unrivaled research product portfolio of over half a million products and end-to-end manufacturing services, Biosynth’s expertise and capability runs across Complex Chemicals, Peptides and Key Biologics all from one trusted partner. Headquartered in Staad, Switzerland, Biosynth is owned by KKR, Ampersand Capital Partners and management. Find out more about Biosynth at www.biosynth.com.

Other members of the Biosynth group are unaffected by the rebranding at this time.

Contacts

Alto Marketing:
Max Kingston - E: maxk@alto-marketing.com; T: +44 7342 385261

Biosynth:
Aimee Cossins – E: marketing@biosynth.com, T: +44 7984 525560

Industry:

Biosynth Carbosynth

Release Versions
EnglishSpanish (Summary)GermanFrenchItalian (Summary)Dutch (Summary)

Contacts

Alto Marketing:
Max Kingston - E: maxk@alto-marketing.com; T: +44 7342 385261

Biosynth:
Aimee Cossins – E: marketing@biosynth.com, T: +44 7984 525560

More News From Biosynth Carbosynth

Biosynth Names Matt Gunnison as CEO, Kieran Murphy Appointed as Chairman

STAAD, Switzerland--(BUSINESS WIRE)--Biosynth, a global supplier of critical raw materials and services to the life sciences industry, today announced that its Board of Directors has appointed Matt Gunnison as the company's new Chief Executive Officer and a member of the Board of Directors, effective immediately. The Board has also appointed Kieran Murphy as Chairman, effective as of the same date. Matt Gunnison will succeed Urs Spitz, under whose guidance Biosynth has achieved remarkable growt...

Opening of Biosynth Biological Technology; a new Cutting-Edge Facility at Lifebay in Suzhou, China

STAAD, Switzerland--(BUSINESS WIRE)--Biosynth, a leading developer and supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceutical industries, is pleased to announce the opening of their Biosynth Biological Technology site at Lifebay, an innovative technology park in Suzhou, China. This new site houses state-of-the-art facilities including a Bio-laboratory which significantly enhances capabilities for internal project development initiatives and material supply...

Biosynth’s Unique Online Custom Peptide Toolset Completed with Full Order Tracking and QC Data Portal

STAAD, Switzerland--(BUSINESS WIRE)--Biosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, is pleased to announce the next step in its custom peptide revolution. In October, Biosynth launched its automated peptide quotation tool for customers with a web account, allowing customers to instantly generate a custom peptide quote. This revolution in speed and ease is now fully integrated to include order tracking and QC documentation, meaning tha...
Back to Newsroom